Speaker illustration

Doctor Kamal Matli

Lebanese American University, Beirut (Lebanon)

Member of:

European Society of Cardiology
Heart Failure Association

Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study

Event: ESC Congress 2022

Topic: Anticoagulants

Session: Challenges and advances in antithrombotic therapy


This platform is supported by

logo Novo Nordisk